Peter Barrett
Chairman bij SYNLOGIC, INC.
Vermogen: 2 M $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Prahlad Singh | M | 59 | 10 jaar | |
| Antoine Awad | M | 44 | 6 jaar | |
| Richard Shea | M | 72 | 21 jaar | |
| Alexis Michas | M | 66 | 23 jaar | |
| Joel Goldberg | M | 55 | 16 jaar | |
| Michael Heffernan | M | 59 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | 5 jaar |
| Mary Dooley | F | 43 | 6 jaar | |
| Michael Celano | M | 65 | 4 jaar | |
| Michelle McMurry-Heath | M | 54 | 2 jaar | |
| Michel Vounatsos | M | 62 | 4 jaar | |
| Nick Leschly | M | 51 | 7 jaar | |
| Michael Gladstone | M | 37 |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 jaar |
| Samuel Chapin | M | 66 | 8 jaar | |
| Maria Fardis | M | 56 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 3 jaar |
| Joseph Truitt | M | 59 | 4 jaar | |
| Bryan A. Kipp | M | - | - | |
| Jodie Morrison | F | 48 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 3 jaar |
| Thomas J. Adam | M | - | 7 jaar | |
| Thomas Hamilton | M | 56 | 4 jaar | |
| Jason Rhodes | M | 54 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 jaar |
| Ommer Chohan | M | - |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 jaar |
| Brendan St Amant | M | - | 3 jaar | |
| Ed Mathers Mathers | M | 64 | 12 jaar | |
| Michael Gilman | M | 69 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 8 jaar |
| Tajinder Vohra | M | 58 | 9 jaar | |
| Yi Ping Lin | F | - | 1 jaar | |
| Pascale Witz | F | 57 | 7 jaar | |
| Jonathan Leff | M | 55 | 4 jaar | |
| Frank R. Witney Witney | M | 70 | 8 jaar | |
| Frank Thomas | M | 54 | 4 jaar | |
| Jean-Francois Formela | M | 67 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 jaar |
| Bruce Booth | M | 49 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 jaar |
| Dave Grayzel | M | 56 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 jaar |
| Kevin Bitterman | M | 47 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 7 jaar |
| Maxwell Krakowiak | M | 35 | 6 jaar | |
| Jayashree Kailas Thacker | F | - | 1 jaar | |
| David Scharfstein | M | 63 |
Harvard Business School
| 21 jaar |
| Fara Goldberg | F | - | - | |
| Magali Four | F | - | 1 jaar | |
| Melanie Call | F | - |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | - |
| Xiangyu Ouyang | M | - |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Miriame Victor | F | 43 | 1 jaar | |
| Pippa Tubman Armerdlng | F | 56 |
Harvard Business School
| 7 jaar |
| Michael Klobuchar | M | 48 | - | |
| Anderson Timothy | M | - |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Anita Gonzales | F | 48 | 1 jaar | |
| Chris Klebanoff | M | - |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | - |
| Caroline Kurtz | M | - | 8 jaar | |
| Carolyn Ng | M | 40 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 7 jaar |
| James Cash | M | 75 |
Harvard Business School
| 48 jaar |
| Daniel Tereau | M | 55 | 10 jaar | |
| Hirotaka Takeuchi | M | 77 |
Harvard Business School
| 48 jaar |
| William Kirby | M | 72 |
Harvard Business School
| 16 jaar |
| Lynn Sharp Paine | M | 74 |
Harvard Business School
| 14 jaar |
| Mark McDade | M | 69 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Juan Arena de la Mora | M | 80 |
Harvard Business School
| - |
| Markus Miele | M | 56 |
Harvard Business School
| - |
| Carl Christian Gilhuus-Moe | M | 80 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Steve Willoughby | M | - | 3 jaar | |
| Johannes Keltjens | M | 67 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Franz Hefti | M | 76 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Anders Götzsche | M | 56 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 4 jaar |
| Robert Ross | M | 50 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 4 jaar |
| Philip Bilden | M | 59 |
Harvard Business School
| - |
| Xiang Yu Ou Yang | M | - |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Sophie Vandebroek | M | 62 | - | |
| Virginia R. Dean | F | 58 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | - |
| Claus Asbjørn Andersson | M | 56 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Robert Woodman | M | 46 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 5 jaar |
| Ankit Mahadevia | M | 43 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | - |
| Shashank Singh | M | 47 |
Harvard Business School
| - |
| Matthew Norkunas | M | 46 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 1 jaar |
| Madhuri Hegde | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Robert Friel | M | 68 | 20 jaar | |
| Craig Wheeler | M | 63 | 14 jaar | |
| Aoife Brennan | M | 48 | 8 jaar | |
| Hong Zhao | M | 60 | - | |
| Jeffrey Moore | M | 63 | 5 jaar | |
| Stanley Lapidus | M | 75 | 8 jaar | |
| Noubar Afeyan | M | 60 | 9 jaar | |
| Andrew Okun | M | 54 | 22 jaar | |
| Todd Shegog | M | 59 | 3 jaar | |
| Stephen J. Lombardi | M | 68 | 4 jaar | |
| John Duncan Higgons | M | 69 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 jaar |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 3 jaar | |
| Ronald Lowy | M | 68 | - | |
| Christoph H. Westphal | M | 56 | 5 jaar | |
| Stephen Hall | M | 73 | 1 jaar | |
| Ken Bate | M | 73 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 jaar |
| David Epstein | M | 65 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 2 jaar |
| Riccardo Pigliucci | M | 77 |
Perkin Elmer Corp.
 Perkin Elmer Corp. BiotechnologyHealth Technology Perkin Elmer Corp. provides solutions for diagnostics, life sciences, food, and applied markets. The private company is based in Norwalk. The American company's accurate and robust instrumentation and sample handling technologies support the work of regulatory bodies and industry scientists in PPCPs analysis. The company's life sciences products include detection and imaging systems, assays and reagents, automation solutions, informatics platforms, and services. | 3 jaar |
| Ira D. Lawrence | M | 71 | 8 jaar | |
| Errol de Souza | M | 70 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 6 jaar |
| Kenton Sicchitano | M | 79 | 16 jaar | |
| Vicki Sato | M | 75 | 16 jaar | |
| Michael Battles | M | 55 | 12 jaar | |
| Patrick Sullivan | M | 72 | 12 jaar | |
| Elizabeth Stoner | M | 73 | 13 jaar | |
| Daniel Marshak | M | 67 | 8 jaar | |
| Nicholas A. Lopardo | M | 77 | 23 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 95 | 95.00% |
| Duitsland | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Peter Barrett
- Persoonlijk netwerk
